ECU
ABBV icon

Eisler Capital (UK)’s AbbVie ABBV Stock Holding History

Eisler Capital (UK)’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$24.7M Buy
124,922
+18,641
+18% +$3.48M 0.11% 159
2024
Q2 		$18.2M Buy
106,281
+18,541
+21% +$3.07M 0.12% 171
2024
Q1 		$16M Buy
87,740
+22,678
+35% +$3.91M 0.13% 154
2023
Q4 		$10.1M Buy
65,062
+40,081
+160% +$5.84M 0.08% 196
2023
Q3 		$3.72M Buy
+24,981
New +$3.67M 0.02% 304

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Eisler Capital (UK)'s ABBV Position: Q3 2024 in Review

Eisler Capital (UK) sold out of AbbVie (ABBV) in Q3 2024, closing a stake of 8,227 shares — an estimated $1.54M sold.

Eisler Capital (UK) first reported a position in ABBV in Q4 2021 and held it in 5 quarters. The position peaked at $4.33M in Q4 2023. 3,498 funds tracked by Wall St. Rank hold ABBV as of Q3 2024.

  • Eisler Capital (UK) reported no remaining AbbVie position as of Q3 2024 after selling out during the quarter.
  • Eisler Capital (UK) sold 8,227 AbbVie shares in Q3 2024, an estimated $1.54M.
  • Eisler Capital (UK) first reported a position in AbbVie in Q4 2021 and held it in 5 quarters.
  • Eisler Capital (UK)'s AbbVie position peaked at $4.33M in Q4 2023.
  • 3,498 funds tracked by Wall St. Rank held AbbVie as of Q3 2024.

Based on Eisler Capital (UK)'s 13F filing for Q3 2024, filed 14 Nov 2024.